Sign in or Register
  |  

Creative Biolabs has successfully developed SARS, MERS and other anti-viral antibodies in the past to assist scientific research. Facing the difficult COVID-19, Creative Biolabs actively invests in antibody development to assist researchers to better understand the characteristics of 2019-nCoV and drug development. Currently, Creative Biolabs is proud to offer an extensive line of research antibodies to support the study of SARS-CoV-2/COVID-19, several of which were validated using virus-infected cell lysates.

Explore the collections of SARS-CoV-2/COVID-19 antibodies >

Tissue Imaging

Creative Biolabs provides high-quality recombinant antibodies which provide clear and reproducible staining imaging.

In fundamental biology and medical diagnostics, there is a constant need to localize and quantify specific molecular targets. Bioimaging comprises the localization and qualitative or quantitative determination of target molecules in and on tissues. There are hundreds of recombinant antibodies for tissue imaging, which are designed to help you obtain high-quality staining results in immunohistochemistry (IHC) and the experiment of tissue imaging.